Q4 FY2025 Earnings
Financial report interval: 2025.10.01 - 2025.12.31
Overview: Novabay Pharmac(NBY) the Revenue is -521 K (--%);the EBIT is -1.824 M (-3.17%);the EPS is -1.34 (-138.2%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
-0.00B--
----
----
EBIT
-0.00B3.17%
----
----
EPS
-1.3379138.22%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf